Josh Lehrer is the founder of Graphite Bio. Graphite Bio has raised $45M in total funding. Latest round: Series A.
Josh Lehrer is the CEO of Graphite Bio, a gene-editing company launched in 2020 in South San Francisco, California. The company focuses on targeted DNA integration to treat severe genetic diseases. He joined Graphite Bio as CEO when the company emerged with $45 million in Series A financing.
Full founder directory · Investor directory · Company funding database · Fundraising library